HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Yoshinaka, Y. Articles by Luftig, R. B. Search for Related Content PubMed PubMed Citation Articles by Yoshinaka, Y. Articles by Luftig, R. B. Agricola Articles by Yoshinaka, Y. Articles by Luftig, R. B.

Physicochemical Characterization and Specificity of the Murine Leukaemia Virus Pr65^gag Proteolytic Factor

Ronald B. Luftig

Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts 01545, U.S.A.

The Pr65^gag proteolytic factor obtained from Moloney (MoLV) or Rauscher (RLV) leukaemia virus has been characterized. We found that it was present in small amounts in virions and was extremely unstable. Although it eluted at the trailing edge of p12 on Sephadex G-75 columns, it could clearly be separated from p12 on DEAE-Sephadex A-50M columns, making it unlikely that the factor is p12 or any other major murine leukaemia virus (MuLV) protein. This fact also distinguishes the murine factor from the avian p15-associated protease which is present in large amounts in avian tumour viruses and is stable to column purification methods (von der Helm, 1977; Dittmar & Moelling, 1978). We further observed that: (i) the murine proteolytic factor had an estimated mol. wt. of 20000 to 22000, relative to MuLV p12, which eluted as a dimer on Sephadex G-75 columns in the presence of 0.1% NP-40; and (ii) in vitro cleavage of an iodinated Pr65^gag-rich, p30-deficient substrate yielded a clear increase in both p30 and p12, which suggests that the in vitro cleavage of Pr65^gag is similar to its processing in vivo.

^* Present address: Department of Microbiology, Mie University School of Medicine, 174 Edobashi-2-Chome, Tsu, Mie, Japan 514.

Please address correspondence to this author at: Department of Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, South Carolina 29208, U.S.A.

Received 25 September 1979; accepted 8 January 1979.